Pages that link to "Q36356082"

The following pages link to Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia (Q36356082):

Displaying 21 items.

• Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications (Q28073464) (← links)
• A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML. (Q36304815) (← links)
• High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis (Q36545112) (← links)
• FLT3 inhibitors: clinical potential in acute myeloid leukemia. (Q37638749) (← links)
• Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia (Q38755213) (← links)
• Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia (Q38902497) (← links)
• Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making (Q39285841) (← links)
• Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation (Q40396505) (← links)
• Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing (Q42322251) (← links)
• Emerging molecular predictive and prognostic factors in acute myeloid leukemia (Q47670541) (← links)
• Methods of Detection of Measurable Residual Disease in AML. (Q47862030) (← links)
• An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia (Q47955491) (← links)
• New chimeric RNAs in acute myeloid leukemia. (Q52328823) (← links)
• Clonal heterogeneity of -ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia (Q56968572) (← links)
• Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes (Q57041027) (← links)
• A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations (Q88333728) (← links)
• Evaluating measurable residual disease in acute myeloid leukemia (Q89081092) (← links)
• Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia (Q89599172) (← links)
• getITD for FLT3-ITD-based MRD monitoring in AML (Q92023294) (← links)
• Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis (Q93023707) (← links)
• Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia (Q95841350) (← links)